Literature DB >> 23677114

Surgical excision after neoadjuvant therapy with vismodegib for a locally advanced basal cell carcinoma and resistant basal carcinomas in Gorlin syndrome.

Anne Lynn S Chang, Scott X Atwood, Danielle M Tartar, Anthony E Oro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23677114      PMCID： PMC4006072          DOI： 10.1001/jamadermatol.2013.30

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

1.  Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.

Authors:  Silvia Buonamici; Juliet Williams; Michael Morrissey; Anlai Wang; Ribo Guo; Anthony Vattay; Kathy Hsiao; Jing Yuan; John Green; Beatriz Ospina; Qunyan Yu; Lance Ostrom; Paul Fordjour; Dustin L Anderson; John E Monahan; Joseph F Kelleher; Stefan Peukert; Shifeng Pan; Xu Wu; Sauveur-Michel Maira; Carlos García-Echeverría; Kimberly J Briggs; D Neil Watkins; Yung-mae Yao; Christoph Lengauer; Markus Warmuth; William R Sellers; Marion Dorsch
Journal:  Sci Transl Med       Date:  2010-09-29       Impact factor: 17.956

2.  Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Authors:  Aleksandar Sekulic; Michael R Migden; Anthony E Oro; Luc Dirix; Karl D Lewis; John D Hainsworth; James A Solomon; Simon Yoo; Sarah T Arron; Philip A Friedlander; Ellen Marmur; Charles M Rudin; Anne Lynn S Chang; Jennifer A Low; Howard M Mackey; Robert L Yauch; Richard A Graham; Josina C Reddy; Axel Hauschild
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

3.  Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.

Authors:  Gerhard Regl; Graham W Neill; Thomas Eichberger; Maria Kasper; Mohammed S Ikram; Josef Koller; Helmut Hintner; Anthony G Quinn; Anna-Maria Frischauf; Fritz Aberger
Journal:  Oncogene       Date:  2002-08-15       Impact factor: 9.867

4.  Initial assessment of tumor regrowth after vismodegib in advanced Basal cell carcinoma.

Authors:  Anne Lynn S Chang; Anthony E Oro
Journal:  Arch Dermatol       Date:  2012-11

5.  Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation.

Authors:  Hideki Yamaguchi; Shuhei Yoshida; Emi Muroi; Nachi Yoshida; Masahiro Kawamura; Zen Kouchi; Yoshikazu Nakamura; Ryuichi Sakai; Kiyoko Fukami
Journal:  J Cell Biol       Date:  2011-06-27       Impact factor: 10.539
  5 in total
  9 in total

1.  Long-term Response to Vismodegib in a Patient with Gorlin-Goltz Syndrome: A Case Report and Review of Pathological Mechanisms Involved.

Authors:  Meghana Kesireddy; Vincent L Mendiola; Bagi Jana; Shrestha Patel
Journal:  Cureus       Date:  2019-08-13

Review 2.  Regulation of the oncoprotein Smoothened by small molecules.

Authors:  Hayley J Sharpe; Weiru Wang; Rami N Hannoush; Frederic J de Sauvage
Journal:  Nat Chem Biol       Date:  2015-04       Impact factor: 15.040

3.  A Prognostic Dilemma of Basal Cell Carcinoma with Intravascular Invasion.

Authors:  Sarah Lonie; Vachara Niumsawatt; Andrew Castley
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-09-27

4.  Gorlin-Goltz syndrome.

Authors:  Betül Şereflican; Bengü Tuman; Murat Şereflican; Sıddıka Halıcıoğlu; Gülzade Özyalvaçlı; Seval Bayrak
Journal:  Turk Pediatri Ars       Date:  2017-09-01

5.  Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases.

Authors:  Kai Yuen Wong; Kate Fife; John T Lear; Richard D Price; Amer J Durrani
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-21

6.  Basal cell carcinoma: multimodal treatment and the role of neoadjuvant vismodegib.

Authors:  Pedro Carvalho Martins; Rita Valença Filipe; Rui Barbosa; Ivo Julião; Rosa Azevedo; Matilde Ribeiro; Abreu de Sousa
Journal:  Autops Case Rep       Date:  2019-09-27

7.  Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry.

Authors:  Aleksandar Sekulic; Simon Yoo; Ragini Kudchadkar; Julie Guillen; Gary Rogers; Anne Lynn S Chang; Scott Guenthner; Bernard Raskin; Keith Dawson; Yong Mun; Laura Chu; Edward McKenna; Mario Lacouture
Journal:  PLoS One       Date:  2022-01-14       Impact factor: 3.240

Review 8.  Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations.

Authors:  Shalini V Mohan; Anne Lynn S Chang
Journal:  Curr Dermatol Rep       Date:  2014-02-09

9.  Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face.

Authors:  Alec M Block; Fiori Alite; Aidnag Z Diaz; Richard W Borrowdale; Joseph I Clark; Mehee Choi
Journal:  Case Rep Oncol Med       Date:  2015-10-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.